SG Americas Securities LLC Invests $822,000 in The Chemours Company (NYSE:CC)

SG Americas Securities LLC bought a new position in The Chemours Company (NYSE:CC) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 60,734 shares of the specialty chemicals company’s stock, valued at approximately $822,000.

Other institutional investors have also made changes to their positions in the company. Strategic Financial Concepts LLC acquired a new position in shares of Chemours during the fourth quarter worth approximately $357,000. State of New Jersey Common Pension Fund D boosted its holdings in Chemours by 9.5% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 111,361 shares of the specialty chemicals company’s stock worth $1,882,000 after buying an additional 9,691 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new position in Chemours during the fourth quarter valued at approximately $996,000. Amalgamated Bank grew its holdings in shares of Chemours by 4.6% in the 4th quarter. Amalgamated Bank now owns 72,714 shares of the specialty chemicals company’s stock valued at $1,229,000 after buying an additional 3,188 shares during the period. Finally, Heritage Investors Management Corp increased its holdings in shares of Chemours by 1.1% in the fourth quarter. Heritage Investors Management Corp now owns 105,322 shares of the specialty chemicals company’s stock worth $1,780,000 after acquiring an additional 1,174 shares in the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Chemours

In other Chemours news, CFO Shane Hostetter acquired 4,450 shares of the business’s stock in a transaction dated Monday, May 19th. The stock was bought at an average price of $11.28 per share, with a total value of $50,196.00. Following the purchase, the chief financial officer now owns 59,694 shares of the company’s stock, valued at approximately $673,348.32. This trade represents a 8.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Damian Gumpel bought 7,822 shares of the stock in a transaction dated Tuesday, June 3rd. The stock was bought at an average cost of $9.95 per share, with a total value of $77,828.90. Following the purchase, the insider now owns 131,701 shares in the company, valued at $1,310,424.95. The trade was a 6.31% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 25,672 shares of company stock valued at $251,573 in the last 90 days. Corporate insiders own 0.47% of the company’s stock.

Wall Street Analysts Forecast Growth

CC has been the subject of several research reports. Royal Bank Of Canada decreased their price target on shares of Chemours from $17.00 to $14.00 and set an “outperform” rating for the company in a research note on Thursday, May 8th. Truist Financial reduced their target price on shares of Chemours from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, April 14th. Barclays lowered their price target on shares of Chemours from $16.00 to $13.00 and set an “equal weight” rating on the stock in a research note on Wednesday, May 28th. Mizuho set a $15.00 price objective on shares of Chemours in a research note on Tuesday, April 15th. Finally, Wall Street Zen cut Chemours from a “hold” rating to a “sell” rating in a report on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Chemours presently has an average rating of “Hold” and an average price target of $17.22.

Chemours Trading Up 2.5%

Shares of Chemours stock opened at $11.01 on Friday. The firm has a market cap of $1.65 billion, a PE ratio of 55.07 and a beta of 1.64. The Chemours Company has a 1 year low of $9.13 and a 1 year high of $25.54. The company has a debt-to-equity ratio of 7.01, a current ratio of 1.75 and a quick ratio of 0.83. The stock has a fifty day moving average price of $11.23 and a 200-day moving average price of $14.74.

Chemours (NYSE:CC) last announced its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a return on equity of 23.82% and a net margin of 0.54%. The firm had revenue of $1.37 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same period last year, the business posted $0.32 EPS. The company’s revenue was up .4% compared to the same quarter last year. Equities research analysts anticipate that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, June 16th. Shareholders of record on Monday, May 19th were issued a $0.0875 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a dividend yield of 3.17%. Chemours’s payout ratio is currently 175.00%.

Chemours Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.